| Folate-targeted therapeutic and imaging agents for cancer PS Low, SA Kularatne Current opinion in chemical biology 13 (3), 256-262, 2009 | 736 | 2009 |
| Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand SA Kularatne, K Wang, HKR Santhapuram, PS Low Molecular pharmaceutics 6 (3), 780-789, 2009 | 267 | 2009 |
| Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted 99mTc-Radioimaging Agents SA Kularatne, Z Zhou, J Yang, CB Post, PS Low Molecular pharmaceutics 6 (3), 790-800, 2009 | 242 | 2009 |
| Synthesis and activity of a folate peptide camptothecin prodrug WA Henne, DD Doorneweerd, AR Hilgenbrink, SA Kularatne, PS Low Bioorganic & medicinal chemistry letters 16 (20), 5350-5355, 2006 | 220 | 2006 |
| CXCR4 expression in prostate cancer progenitor cells A Dubrovska, J Elliott, RJ Salamone, GD Telegeev, AE Stakhovsky, ... PloS one 7 (2), e31226, 2012 | 187 | 2012 |
| Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor‐specific fluorescent ligands W He, SA Kularatne, KR Kalli, FG Prendergast, RJ Amato, GG Klee, ... International journal of cancer 123 (8), 1968-1973, 2008 | 182 | 2008 |
| Synthesis and biological analysis of prostate-specific membrane antigen-targeted anticancer prodrugs SA Kularatne, C Venkatesh, HKR Santhapuram, K Wang, B Vaitilingam, ... Journal of medicinal chemistry 53 (21), 7767-7777, 2010 | 172 | 2010 |
| Targeting of nanoparticles: folate receptor SA Kularatne, PS Low Cancer Nanotechnology: Methods and Protocols, 249-265, 2010 | 147 | 2010 |
| PSMA binding ligand-linker conjugates and methods for using PS Low, SA Kularatne US Patent 9,193,763, 2015 | 118* | 2015 |
| Development of tumor-targeted near infrared probes for fluorescence guided surgery LE Kelderhouse, V Chelvam, C Wayua, S Mahalingam, S Poh, ... Bioconjugate chemistry 24 (6), 1075-1080, 2013 | 117 | 2013 |
| Evaluation of novel tumor-targeted near-infrared probe for fluorescence-guided surgery of cancer SM Mahalingam, SA Kularatne, CH Myers, P Gagare, M Norshi, X Liu, ... Journal of medicinal chemistry 61 (21), 9637-9646, 2018 | 108 | 2018 |
| Ligand‐targeted delivery of small interfering RNAs to malignant cells and tissues M Thomas, SA Kularatne, L Qi, P Kleindl, CP Leamon, MJ Hansen, ... Annals of the New York Academy of Sciences 1175 (1), 32-39, 2009 | 107 | 2009 |
| Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis YYJ Gent, K Weijers, CFM Molthoff, AD Windhorst, MC Huisman, ... Arthritis research & therapy 15, 1-11, 2013 | 87 | 2013 |
| A CXCR4‐Targeted Site‐Specific Antibody–Drug Conjugate SA Kularatne, V Deshmukh, J Ma, V Tardif, RKV Lim, HM Pugh, Y Sun, ... Angewandte Chemie International Edition 53 (44), 11863-11867, 2014 | 82 | 2014 |
| Comparison of folate receptor targeted optical contrast agents for intraoperative molecular imaging E De Jesus, JJ Keating, SA Kularatne, J Jiang, R Judy, J Predina, S Nie, ... International Journal of Molecular Imaging 2015 (1), 469047, 2015 | 81 | 2015 |
| Evaluation of novel prostate-specific membrane antigen-targeted near-infrared imaging agent for fluorescence-guided surgery of prostate cancer SA Kularatne, M Thomas, CH Myers, P Gagare, AK Kanduluru, CJ Crian, ... Clinical Cancer Research 25 (1), 177-187, 2019 | 79 | 2019 |
| Identification of a folate receptor-targeted near-infrared molecular contrast agent to localize pulmonary adenocarcinomas JD Predina, AD Newton, C Connolly, A Dunbar, M Baldassari, ... Molecular Therapy 26 (2), 390-403, 2018 | 68 | 2018 |
| Folate receptor beta designates immunosuppressive tumor-associated myeloid cells that can be reprogrammed with folate-targeted drugs GM Cresswell, B Wang, EM Kischuk, MM Broman, RA Alfar, RE Vickman, ... Cancer research 81 (3), 671-684, 2021 | 62 | 2021 |
| Buried solvent determines both anion-binding selectivity and binding stoichiometry with hydrogen-bonding receptors DH Burns, K Calderon-Kawasaki, S Kularatne The Journal of Organic Chemistry 70 (7), 2803-2807, 2005 | 58 | 2005 |
| Intraoperative molecular imaging combined with positron emission tomography improves surgical management of peripheral malignant pulmonary nodules JD Predina, AD Newton, J Keating, EM Barbosa Jr, O Okusanya, L Xia, ... Annals of surgery 266 (3), 479-488, 2017 | 57 | 2017 |
Philip S. LowProfessor of Chemistry, Purdue UniversityE-mail megerősítve itt: purdue.edu